Case Series

Clinical Management of Children and Adolescents with Neurofibromatosis Type 1 Like Phenotypes and Complex Behavioural Manifestations: A Multidisciplinary and Dimensional Approach

Table 2

Clinical profile of NF1 patients with subnormal IQ.

Patient 5Patient 6Patient 7Patient 8Patient 9Patient 10Patient 11

Sex, ageMale, 10 yearsMale, 8 yearsMale, 8 yearsMale, 9 yearsMale, 15 yearsMale, 7 yearsMale, 12 years

Main reason for referralLearning difficultiesLearning difficultiesLearning difficultiesIntermittent explosive behaviour; ADHDConfirmation of ASD (ADOS-ADI-R)Suspicion of ADHDMood disorder
Anxiety symptomsBehavioural difficultiesHyperactivity sleep; family related issuesNF1 complications: Precocious puberty; nondysplastic scoliosis; UBOs: cerebellum, globus pallidusEmotional labilityNF1 related stressLearning difficulties
Social difficulties
Outpatient unitOutpatient unitOutpatient unitOutpatient unitOutpatient unitOutpatient unitOutpatient unit

NF1 diagnosisFamilial NF1Familial NF1Sporadic NF1Sporadic NF1Sporadic NF1Sporadic NF1Legius SD

Developmental delayMinor (graphic abilities)NoMinor (global motor)Walking unstable at 21 months???NoNot reported
Repeated otitisPrematuritySpeech delay (Repeated otitis)

Cognitive assessment WISC-IVVerbal: 92; performance: 121; working memory: 97; speed: 88Verbal: 86; performance: 77; working memory: 73; speed: 71Verbal: 92; performance: 94; working memory: 76; speed: 78Verbal: 98; performance: 65; working memory: 82; speed: 83Verbal: 86; performance: 73; working memory: 109; speed: 100Verbal: 92; performance: 109; working memory: 91; speed: 103Verbal: 94; performance: 90; working memory: 73; speed: 66
HeterogeneousHeterogeneousHeterogeneousHeterogeneousHeterogeneousHeterogeneousHeterogeneous

Attention and executive functionsDivided attention TEA-Ch: −2SDDivided attention TEA-Ch: −1.4SDDivided attention TEA-Ch: NormalDivided attention TEA-Ch: −0.5SDDivided attention TEA-Ch: +0.7SD
Unimodal attention TEA-Ch: NormalUnimodal attention TEA-Ch: −1.4SDUnimodal attention TEA-Ch: NormalUnimodal attention TEA-Ch: −0.7SDUnimodal attention: TEA-Ch +0.3SDUnimodal attention TEA-Ch: −0.7SD
Sustained attention TEA-Ch: −1.7SD
Attention control TEA-Ch: -2.2SDAttention control TEA-Ch: +0.7SD
Inhibition TEA-Ch: −2SDInhibition TEA-Ch: +1SD
Flexibility NEPSY-II: −0.1SDFlexibility NEPSY-II: −1.5SDFlexibility NEPSY-II: −0.5SDFlexibility NEPSY-II: −1.5SDFlexibility NEPSY-II: −1.4SDFlexibility NEPSY-II: −0.1SDFlexibility NEPSY-II: −0.2SD

MemoryShort-term NEPSY-II: −0.1SDShort-term NEPSY-II: −1.2SDShort-term: −1.6SDShort-term NEPSY-II: −0.3SDShort-term NEPSY-II: −0.7SDShort-term NEPSY-II: −0.3SD
Episodic REY: −0.3SDEpisodic REY: +0.5SDEpisodic REY: +0.4SDEpisodic REY: −3SD

Language assessment EXALANGOral receptive: -0.7SDOral receptive: −1.5SDOral expressive: +1.4SDNormalNormalNormalOral lexicon: −1.3SD
Oral expressive: −0.5SDOral expressive: −2SDOral lexicon: −0.5SD
Oral lexicon: +0.7SDOral lexicon: −1.2SD
Written receptive: −2.6SDWritten expressive: −1.7SDWritten receptive: +1.4SWritten expressive: −2.6
Written expressive: −2.9SDWritten expressive: −0.5SD
Spelling: −2.6SD

MotricityVisuo-construction REY: +0.5SDVisuo-construction REY: NormalVisuo-construction REY: −0.7SDVisuo-construction REY: −3SDVisuo-construction REY: −0.3SDVisuo-construction REY: +0.2SDVisuo-construction REY: −0.7SD
Visuo-spatial NEPSY-II: +0.5SDVisuo-spatial NEPSY-II: −0.6SDVisuo-spatial NEPSY-II: −0.3SDVisuo-spatial NEPSY-II: −0.1SDVisuo-spatial NEPSY-II: −0.8SDVisuo-spatial NEPSY-II: +0.3SDVisuo-spatial NEPSY-II: −0.8SD
Graphomotor skill BHK: −2.3SDGraphomotor skill BHK: −2SDGraphomotor skill BHK: −2SDGraphomotor skill BHK: −2SDGraphomotor skill BHK: +1.4SDGraphomotor skill BHK: +0.4SDGraphomotor skill BHK: −0.3SD

Socio-cognition/pragmatic−0.7SD−0.3SD−2.2SD−1SDNormal

Psychiatric DiagnosisADHD-inattentive typeBorderline intelligenceAnxious disorderBorderline intelligenceASD (Asperger)Anxiety disorderMood disorder
DyslexiaADHD-impulsive typeMotor (graphic) delayADHD, ODDDysexecutive profileAttachment disorder
Pragmatic communication disorderDysexecutive profileVisual-Spatial DyspraxiaDyspraxiaWritten language difficulties
At risk for dyslexiaDysgraphiaNF1 related stress

MedicationMethylphenidateMethylphenidate (not well tolerated)MelatoninMethylphenidateAripiprazoleNoneQuetiapine
Triptorelin Acetate

Nonpharmacological treatmentSpecific school adaptationsSpecific school adaptationsSpecific school adaptationsSpecific school adaptations
Speech and reading therapySpeech and reading therapySpeech and reading therapy (past)Language and motor remediation in the pastSpeech and reading therapy
Motor skills remediationMotor skills remediationMotor skills remediationMotor skills remediationSocial strategies group
PsychotherapyPsychodrama therapyPsychotherapyPsychiatric follow-up

OutcomeImprovementImprovementStableImprovementStableStableStable

ADHD, attention deficit hyperactivity disorder; ADI-R, autism diagnostic interview-Revised [15]; ADOS, autism diagnostic observation schedule [16]; ASD, autism spectrum disorder; BHK, concise evaluation scale for children handwriting [17]; EMOTION COMPREHENSION TEST, Test of emotion comprehension [27]; EXALANG, language evaluation for children 8–11 years [21]; NEPSY-II, Neuropsychological test for children [22]; NF1, Neurofibromatosis type 1; ODD, oppositional defiant disorder; TEA-Ch, test of everyday attention for children [24]; REY, Rey’s complex figure test [25]; UBOs, unidentified bright objects]; WISC IV, the Wechsler intelligence scale for children [29].